Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease)

Abstract

Background and ObjectiveMatrix metalloproteinase (MMP) -8, -9 and myeloperoxidase (MPO) are inflammatory mediators. The potential associations between MMP-8, -9, MPO and their abilities to reflect cardiovascular risk remains to be evaluated in saliva. The objective of this study was to investigate the levels and associations of salivary MMP-8, -9, MPO and tissue inhibitors of metalloproteinase (TIMP)-1 in myocardial infarction (MI) patients and controls with or without periodontitis.Materials and Methods200 patients with a first MI admitted to coronary care units in Sweden from May 2010 to December 2011 and 200 controls matched for age, gender, residential area and without previous MI were included. Dental examination and saliva sample collection was performed 6-10 weeks after the MI in patients and at baseline in controls. The biomarkers MMP -8, -9, MPO and TIMP-1 were analyzed by time-resolved immunofluorescence assay (IFMA), Western blot and Enzyme-Linked ImmunoSorbent Assay (ELISA).ResultsAfter compensation for gingivitis, gingival pockets and smoking, the mean salivary levels of MMP-8 (543 vs 440 ng/mL, p = 0.003) and MPO (1899 vs 1637 ng/mL, p = 0.02) were higher in non-MI subjects compared to MI patients. MMP-8, -9 and MPO correlated positively with clinical signs of gingival/periodontal inflammation while TIMP-1 correlated mainly negatively with these signs. The levels of latent and active forms of MMP-8 did not differ between the MI and non-MI groups. Additionally, MMP-8, MPO levels and MMP-8/TIMP-1 ratio were significantly higher in men compared to women with MI.ConclusionsThis study shows that salivary levels of the analyzed biomarkers are associated with periodontal status. However, these biomarkers could not differentiate between patients with or without a MI. These findings illustrate the importance to consider the influence of oral conditions when analyzing levels of inflammatory salivary biomarkers.

Clinical concentrations of peroxidases cause dysbiosis in in vitro oral biofilms

“…The results of our study showed that salivary concentrations of lactoperoxidase and myeloperoxidase increased the growth of pathobionts by 1‐2 Log 10 Geq/mL in multispecies biofilms. These data are in line with recent clinical studies, which indicated a positive correlation between myeloperoxidase concentrations in saliva and clinical signs of gingival or periodontal diseases …”

Saliva and plasma levels of cardiac‐related biomarkers in post‐myocardial infarction patients

“…Dental examination followed a standardized protocol (Rathnayake et al., ) and comprised number of present teeth, soft tissue pathologies, dental caries and periodontal status, including probing pocket depth (PPD) at four sites (buccal‐proximal‐lingual) per tooth, bleeding on probing (BOP) and present or absent plaque score. PPD was measured parallel to the tooth with a periodontal probe with 1 mm grading (Hu‐Friedy PCPUNC15).…”

Smoking confounds the periodontal diagnostics using saliva biomarkers

“…On the other hand, saliva TIMP‐1 was elevated in smokers compared with non‐smokers both in periodontitis and control subjects . Smokers had, especially in serum, elevated MPO compared with non‐smokers, but when analyzed in saliva, MPO did not differ significantly according to smoking status …”